Temozolomide in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to Cisplatin

NCT00006043 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Ovarian Cancer
Testicular Germ Cell Tumor

Interventions

DRUG: temozolomide

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]